Effective July 1, 2019, healthcare providers in Florida (with the exception of pharmacists) must provide patients with information regarding non-opioid alternative drugs and treatments before they can provide anesthesia or prescribe, order, dispense or administer a Schedule II opioid drug for the treatment of pain. Providers must also discuss the advantages and disadvantages of the non-opioid alternatives and provide an educational pamphlet.

For healthcare providers, it is important to note that the new law does not apply to:

  • The prescribing, ordering, administering or dispensing of a Schedule II opioid for reasons other than the treatment of pain
  • The prescribing, ordering, administering or dispensing of a Schedule III-V opioid, even if it is for the treatment of pain

The informational pamphlet lists a number of non-opioid medications, interventions and treatments, including topical treatments (compounds) and medications (NSAIDs, neuropathic agents and muscle relaxers), chiropractic treatment, acupuncture, and over-the-counter medications such as acetaminophen and NSAIDs).

The pamphlet is posted to the Florida Department of Health Website.

The FisherBroyles Pharmacy and Health Care Law team is pleased to keep you updated on events of interest to those in the healthcare, medical device, and pharmaceutical industries. Questions may be directed to any of the following attorneys:

Brian Dickerson, FisherBroyles Partner
Brian E. Dickerson
brian.dickerson@fisherbroyles.com
202.570.0248

Anthony Calamunci, FisherBroyles Partner
Anthony Calamunci
Anthony.calaunci@fisherbroyles.com
419.376.1776

Nicole Waid, FisherBroyles Partner
Nicole Hughes Waid
nicole.waid@fisherbroyles.com
202.906.9572

Amy Butler, FisherBroyles Partner
Amy Butler
amy.butler@fisherbroyles.com
419.340.8466

Catherine Kahle, FisherBroyles Partner
Catherine Kahle
catherine.kahle@fisherbroyles.com
239.699.8071